Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: relationship with stearoyl-CoA desaturase activity - Wikidata - wikimedia - TriplyDB

Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: relationship with stearoyl-CoA desaturase activity

Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: relationship with stearoyl-CoA desaturase activity

http://www.wikidata.org/entity/Q35000419

about

Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance Lipid-lowering effects of tetradecylthioacetic acid in antipsychotic-exposed, female rats: challenges with long-term treatment Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain.Omega-3 fatty acid deficiency augments risperidone-induced hepatic steatosis in rats: positive association with stearoyl-CoA desaturase.Fatty Acid desaturase gene polymorphisms and metabolic measures in schizophrenia and bipolar patients taking antipsychotics.Depot risperidone-induced adverse metabolic alterations in female rats.Curcumin Activates AMPK Pathway and Regulates Lipid Metabolism in Rats Following Prolonged Clozapine Exposure.Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats.Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects.Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.

P2860

Q28553078-4CCF0190-B489-4EDC-974C-3A868D7C0AE7 Q28555023-0D7CA313-1F14-4788-9941-4293A95455F5 Q34506022-9691AAFF-B05E-458F-B3B5-D713EFF8085B Q35284832-BADD92B1-3369-417E-8CBC-6E88ECD792D3 Q36164661-DE9ABD37-D3C8-4E0C-8BF0-1AF59467F178 Q37433174-342A3945-FB5C-4326-9F61-031029CD7D5D Q38873420-869E7E12-727D-4A91-AE9D-DB867297A4DD Q42372740-6F5ECEFC-3676-4681-938A-93EB99E9C613 Q47130611-DBB4D9CA-1D13-4E70-AF39-9D17D57705ED Q47359953-9E837E57-FB1B-4DC3-A5BF-697D5BA698B0 Q47847071-96A3C6DC-A068-4CFD-AED2-5AAFDBEAEEBE Q54662194-3E4348DF-BE59-4F88-ADF4-AE97C1B6B82A

P2860

Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: relationship with stearoyl-CoA desaturase activity

http://www.wikidata.org/entity/Q35000419

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Atypical antipsychotic medicat ...... earoyl-CoA desaturase activity

@ast

Atypical antipsychotic medicat ...... earoyl-CoA desaturase activity

@en

type

label

Atypical antipsychotic medicat ...... earoyl-CoA desaturase activity

@ast

Atypical antipsychotic medicat ...... earoyl-CoA desaturase activity

@en

prefLabel

Atypical antipsychotic medicat ...... earoyl-CoA desaturase activity

@ast

Atypical antipsychotic medicat ...... earoyl-CoA desaturase activity

@en

P1433

Q35000419-49A8E9C5-7773-41CA-99A2-3DCF99CF975C

P1476

Q35000419-5CAE46DD-F6AF-4347-B9D1-334D918255B5

P2093

Q35000419-0747787D-7804-42AC-8A75-E9C8D4566362

Q35000419-7239CA54-39CB-4C0E-A912-5F1C697BE70E

Q35000419-8084B4BF-650D-4F0C-B1CF-3BFD4DDD8E86

Q35000419-833DF11E-710F-418E-BC03-1B52431BCBDF

Q35000419-8A5671C0-BDA1-446A-AA7C-3E1E7126CCAC

Q35000419-CF88917D-F6C5-44BE-B1C9-52A65297657B

P2860

Q35000419-068BB861-3756-4F02-BDFF-80462150BE2A

Q35000419-146BD398-4846-4420-BEA0-80C6DA731943

Q35000419-15DE8E80-8004-45D6-AAFE-301CA83A41F0

Q35000419-19BF21B8-4B67-4371-8F3E-04C78BEAE5C0

Q35000419-25296125-22D4-4E2B-8D93-AB2F49BFC55B

Q35000419-3666A2C5-BEBA-4B9B-BD65-982B8804D9FF

Q35000419-3C0FAC3A-CB76-4BAB-8F70-CEDCC03D287D

Q35000419-3F71AC67-55AA-4BD2-A64E-617F358934C9

Q35000419-42E7BE67-8752-48C3-A616-B3DC2468D028

Q35000419-44E69CF8-F0A1-4BFE-AF3E-721E4E0D2CBB

P304

Q35000419-39F6A5A6-29C8-4510-A87A-41405C7A7278

P31

Q35000419-E42C0867-065D-49D9-B3ED-A994BE507B29

P356

Q35000419-E4EB2610-7E94-4DFF-8C61-F010CE0DD744

P407

Q35000419-3606CB10-040E-4760-A30E-46CC9AB2307F

P433

Q35000419-8B5F8D6F-E846-47C3-A2E9-F3E75CA2F6EC

P478

Q35000419-1963AB87-6C9C-4B34-8377-DC97FEFF1155

P577

Q35000419-FE4ACE24-3922-4A21-9A58-93E427F70A89

P5875

Q35000419-79DA75AA-86CE-438B-B536-CD18EED738CE

P698

Q35000419-44B385E3-187D-481C-8C89-78528FCA5794

P921

Q35000419-989C0BA4-2F6D-4413-B1A2-6541D03FDE4B

P932

Q35000419-5E2FB637-7894-46FA-A521-333EAC98D139

P356

J.SCHRES.2011.03.016

P1433

Schizophrenia Research

P1476

Atypical antipsychotic medicat ...... earoyl-CoA desaturase activity

@en

P2093

Allyson Cole-Strauss

http://www.w3.org/2001/XMLSchema#string

Jack W Lipton

http://www.w3.org/2001/XMLSchema#string

Patrick Tso

http://www.w3.org/2001/XMLSchema#string

Robert K McNamara

http://www.w3.org/2001/XMLSchema#string

Ronald Jandacek

http://www.w3.org/2001/XMLSchema#string

Therese Rider

http://www.w3.org/2001/XMLSchema#string

P2860

Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia

Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans

The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1

Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia.

Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol.

Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity

Opposing effects of omega-3 and omega-6 long chain polyunsaturated Fatty acids on the expression of lipogenic genes in omental and retroperitoneal adipose depots in the rat

Effects of atypical antipsychotics on weight and serum lipid levels.

P304

66-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SCHRES.2011.03.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

129

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51033579

http://www.w3.org/2001/XMLSchema#string

P698

21474290

http://www.w3.org/2001/XMLSchema#string

P921

P932

3100393

http://www.w3.org/2001/XMLSchema#string